US recommends pause for Johnson & Johnson vaccine over clot reports

US federal distribution channels, including mass vaccination sites, will pause the use of the JJ shot and states and other providers are expected to follow.

CDCs Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases.

“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr Anne Schuchat Principal Deputy Director of the CDC and Dr Peter Marks director of the FDAs Center for Biologics Evaluation and Research said in a joint statement.